Comments of DPR's RCD for Simazine
Comments of DPR's RCD for Simazine
OEHHA has provided a number of comments on the risk characterization methodology and conclusions on the draft RCD for Simazine. These comments and our recommendations, as well as suggested clarifications, additions and corrections, are contained in this report.
- Simazine